JAK2 and hepatocellular carcinoma: Studies have confirmed that circRNAs can act via the AKT/ERK21, Wnt/β-catenin22, nuclear factor-kappa B23, hedgehog24, c-Met25, JAK2/STAT326 and other signalling pathways and are involved in the malignant biological behaviours of HCC.